Codes / ICD10CM / T39.092D

T39.092D Poisoning by salicylates, intentional self-harm, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by salicylates, intentional self-harm, subsequent encounter (ICD-10 Code: T39.092D)

Summary

This condition represents intentional self-harm poisoning by salicylates during a subsequent encounter. Salicylates, including aspirin and related compounds, are widely used for pain relief, anti-inflammatory effects, and cardiovascular protection. Intentional self-harm involves deliberate ingestion of excessive amounts, leading to systemic toxicity. The severity depends on the dose, individual metabolism, and prior medical intervention. Subsequent encounters indicate follow-up care after the initial episode.

Causes

Intentional self-harm poisoning by salicylates results from deliberate overdose, often driven by psychological distress or suicidal intent. Contributing factors may include access to salicylate-containing medications, lack of supervision, or underlying mental health conditions. The act of self-harm may involve single or repeated ingestion, with toxicity arising from the cumulative dose.

Risk Factors

  • Mental health conditions: Depression, anxiety, or other psychiatric disorders increase risk.
  • Prior self-harm history: Previous attempts elevate the likelihood of recurrence.
  • Access to medications: Unrestricted access to salicylates or other substances.
  • Social isolation: Lack of support systems or monitoring.
  • Substance use: Co-occurring alcohol or drug use may impair judgment.

Symptoms

  • Gastrointestinal: Nausea, vomiting, abdominal pain, or hematemesis.
  • Neurological: Dizziness, confusion, seizures, or coma.
  • Respiratory: Hyperventilation, respiratory alkalosis, or pulmonary edema.
  • Metabolic: Metabolic acidosis, electrolyte imbalances, or hypoglycemia.
  • Other: Tinnitus, sweating, or fever.

Diagnosis

Diagnosis is based on clinical presentation, history of intentional ingestion, and laboratory findings. Serum salicylate levels confirm exposure, while arterial blood gas analysis assesses acid-base status. Additional tests may include electrolyte panels, renal function studies, or toxicology screens to rule out co-ingestants. Imaging (e.g., chest X-ray) evaluates for pulmonary complications.

Treatment Options

Treatment focuses on stabilizing the patient and reducing salicylate absorption. Interventions may include activated charcoal (if within hours of ingestion), intravenous fluids for hydration, and alkalinization of urine to enhance excretion. Severe cases may require hemodialysis. Psychiatric evaluation and support are critical for addressing underlying intent.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, timeliness of treatment, and presence of complications. Early intervention improves outcomes, but severe toxicity can lead to organ damage or death. Follow-up care includes monitoring for recurrence, psychiatric counseling, and safety planning. Long-term management may involve medication adjustments or mental health support.

Complications

  • Gastrointestinal: Ulceration, bleeding, or perforation.
  • Renal: Acute kidney injury or failure.
  • Neurological: Cerebral edema or permanent cognitive impairment.
  • Metabolic: Severe acidosis or electrolyte disturbances.
  • Respiratory: Acute respiratory distress syndrome (ARDS).

Lifestyle & Prevention

  • Secure medications: Store salicylates in locked cabinets to prevent access.
  • Mental health support: Seek counseling for underlying psychological issues.
  • Education: Learn proper dosing and storage of medications.
  • Supervision: Ensure children or vulnerable individuals are monitored.
  • Follow-up: Attend scheduled psychiatric or medical appointments.

When to Seek Professional Help

Seek immediate care for suspected overdose, especially with symptoms like vomiting, confusion, or difficulty breathing. Contact emergency services or a poison control center. Follow up with healthcare providers for ongoing mental health support or if symptoms persist.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Include details on treatment, complications, and psychiatric evaluation to support coding accuracy. Ensure the record reflects the timeline of care and any relevant comorbidities.

Book a walkthrough

T39.092D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.